Civic Intelligence

Abzyme Research Foundation

990EZ • Fiscal year 2017 • EIN 27-3438658

Jan 01, 2017 to Dec 31, 2017 • Filed on Aug 19, 2019

67 Irving Place 12th FLNew York, NY 10003

(347) 967-3734

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

74th percentile

0.01x

Higher debt load relative to assets than 74% of similar nonprofits.

2017 filings • NTEE H • <$500k nonprofits • Source year 2017

Liabilities / Revenue

76th percentile

0.01x

Higher debt load relative to revenue than 76% of similar nonprofits.

2017 filings • NTEE H • <$500k nonprofits • Source year 2017

Net Margin

5th percentile

-332%

Higher net margin than 5% of similar nonprofits.

2017 filings • NTEE H • <$500k nonprofits • Source year 2017

Top Officer Pay

97th percentile

$78,924

Higher top officer pay than 97% of similar nonprofits.

Top officer pay equals 45.8% of source-year revenue.

2017 filings • NTEE H • <$500k nonprofits • Source year 2017

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Assets

$385,535

No earlier filing loaded for comparison.

Net Assets

$383,320

No earlier filing loaded for comparison.

Liabilities

$2,215

No earlier filing loaded for comparison.

Revenue

$172,225

No earlier filing loaded for comparison.

Expenses

$744,547

No earlier filing loaded for comparison.

Net Income

-$572,322

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2017: $385,535Liabilities 2017: $2,215Net Assets 2017: $383,3202017Assets 2018: $351,372Liabilities 2018: $10,750Net Assets 2018: $340,6222018Assets 2019: $353,342Liabilities 2019: $0Net Assets 2019: $353,3422019Assets 2020: $344,776Liabilities 2020: $0Net Assets 2020: $344,7762020Assets 2021: $341,865Liabilities 2021: $0Net Assets 2021: $341,8652021Assets 2022: $336,178Net Assets 2022: $336,1782022Assets 2023: $328,979Net Assets 2023: $328,9792023Assets 2024: $335,298Net Assets 2024: $335,2982024

Highlighted filing

2017

Assets$385,535
Liabilities$2,215
Net Assets$383,320

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500K-$1.0MRevenue 2017: $172,225Expenses 2017: $744,547Net Income 2017: -$572,3222017Revenue 2018: $84,666Expenses 2018: $127,364Net Income 2018: -$42,6982018Revenue 2019: $60,108Expenses 2019: $32,293Net Income 2019: $27,8152019Revenue 2020: $5,394Expenses 2020: $13,960Net Income 2020: -$8,5662020Revenue 2021: $139Expenses 2021: $3,050Net Income 2021: -$2,9112021Revenue 2022: $52Expenses 2022: $5,739Net Income 2022: -$5,6872022Revenue 2023: $23Expenses 2023: $7,223Net Income 2023: -$7,2002023Revenue 2024: $10,001Expenses 2024: $3,682Net Income 2024: $6,3192024

Highlighted filing

2017

Revenue$172,225
Expenses$744,547
Net Income-$572,322
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Aug 19, 2019
Return Version
2017v2.3
Gross Receipts
$172,225
Mission and Program Overview

Mission

Advance the development of abzyme technology in the hopes of producing the world's first effective hiv vaccine and improved treatment for over 36 million hiv-positive people worldwide.

Program Services

DescriptionGrantsExpenses
THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA. AS WELL AS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND$325,000$393,964
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
ZACHARY BARNETTExecutive DirectorFT$71,500$7,424$78,924
ADAM MACLEANVice-Chair-$0--
NICHOLAS SMITHTreasurer-$0--
AIMEE A DROUINSecretary-$0--
MICHAEL JEFVERTDirector-$0--
VALERIE KERRCo-Chair-$0--
ELIZABETH MILLERDirector-$0--
DAVE SONGDirector-$0--
Filing and Contact Details

Filer

Filer Name
Abzyme Research Foundation
EIN
27-3438658
Phone
3479673734
Address
67 IRVING PLACE 12TH FL, NEW YORK, NY 10003

Signing Officer

Name
Zachary Barnett
Title
Executive Director
Phone
3479673734
Signed
2019-08-19
Discuss with paid preparer
Yes

Preparer

Firm
Skody Scot & Co Cpas Pc
Address
520 EIGHTH AVE SUITE 2200, NEW YORK, NY 10018
Preparer
Laurence Scot Mba CPA
Phone
2129671100
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 4 - Other Investment Income

Description: interest. Amount: 155.

Form 990-ez, Part I, Line 10 - Grants and Similar Amounts Paid

Activity classification: research grants. Grantee name: university of texas. Grantee address: 110 inner campus drive austin, tx 78705. Grantee relationship: none. Date of gift: 08/16/17. Amount given: 325,000.

Form 990-ez, Part I, Line 16 - Other Expenses

Description: bad debt. Amount: 250,000. Description: insurance. Amount: 1,495. Description: marketing. Amount: 17,908. Description: office expenses. Amount: 10,372. Description: travel and meetings. Amount: 20,405. Total to form 990-ez, line 16: 300,180.

Form 990-ez, Pages 1-4

Changes due to filing an amended return: upon completion of the independent financial audit, amounts and disclosures on most parts of the originally filed 990-ez return changed. The following is a summary of originally reported amounts: 990-ez, page 1 total revenue (line 9) 142,225 total expenses(line 9) 744,548

Form 990-ez, Part II, Line 24 - Other Assets

Description: contributions receivable. Beg. Of year amount: 675,500. End of year amount: 30,000. Description: investment in covalent bioscien. Beg. Of year amount: 235,824. End of year amount: 235,824. Description: prepaid expenses. Beg. Of year amount: 3,583. End of year amount: 2,953. Description: account receivable. Beg. Of year amount: 1,814. End of year amount: 0.

Form 990-ez, Part II, Line 26 - Other Liabilities

Description: accounts payable and accrued expenses. Beg. Of year amount: 13,890. End of year amount: 2,215.

Form 990-ez, Pages 1-4

Changes due to filing an amended return: upon completion of the independent financial audit, amounts and disclosures on most parts of the originally filed 990-ez return changed. The following is a summary of originally reported amounts: 990-ez, page 2 total assets (line 25) 355,534 total liabilities(line 9) 2,215 net assets-end of year (line 27) 353,319

Raw XML Appendix193 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/AmendedReturnInd0X
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum03479673734
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FL
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010003
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt052811
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0116758
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt0172070
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-572322
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt035738
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0969532
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0385535
IRS990EZ/GrantsAndSimilarAmountsPaidAmt0325000
IRS990EZ/GrossReceiptsAmt0172225
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InvestmentIncomeAmt0155
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0955642
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0383320
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0955642
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0383320
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt04.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt750.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt771500
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt77424
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0ADAM MACLEAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1NICHOLAS SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2AIMEE A DROUIN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3MICHAEL JEFVERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4VALERIE KERR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5ELIZABETH MILLER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6DAVE SONG
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7ZACHARY BARNETT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0VICE-CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4CO-CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7EXECUTIVE DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0916721
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0268777
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt0300180
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0ADVANCE THE DEVELOPMENT OF ABZYME TECHNOLOGY IN THE HOPES OF PRODUCING THE WORLD'S FIRST EFFECTIVE HIV VACCINE AND IMPROVED TREATMENT FOR OVER 36 MILLION HIV-POSITIVE PEOPLE WORLDWIDE.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA. AS WELL AS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt0325000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0393964
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt083629
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NY
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt013890
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt02215
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0744547
IRS990EZ/TotalProgramServiceExpensesAmt0393964
IRS990EZ/TotalRevenueAmt0172225
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ENDHIV.COM
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0142070
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01097580
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0441682
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0132580
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0205863
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt02019775
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0155
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt034
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt08
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt03
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0200
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.63370
IRS990ScheduleA/PublicSupportPY170Pct00.59450
IRS990ScheduleA/PublicSupportTotal170Amt01280075
IRS990ScheduleA/SubstantialContributorsTotAmt0739700
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0142070
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01097580
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0441682
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0132580
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0205863
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt02019775
IRS990ScheduleA/TotalSupportAmt02019975
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INTEREST. AMOUNT: 155.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ACTIVITY CLASSIFICATION: RESEARCH GRANTS. GRANTEE NAME: UNIVERSITY OF TEXAS. GRANTEE ADDRESS: 110 INNER CAMPUS DRIVE AUSTIN, TX 78705. GRANTEE RELATIONSHIP: NONE. DATE OF GIFT: 08/16/17. AMOUNT GIVEN: 325,000.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: BAD DEBT. AMOUNT: 250,000. DESCRIPTION: INSURANCE. AMOUNT: 1,495. DESCRIPTION: MARKETING. AMOUNT: 17,908. DESCRIPTION: OFFICE EXPENSES. AMOUNT: 10,372. DESCRIPTION: TRAVEL AND MEETINGS. AMOUNT: 20,405. TOTAL TO FORM 990-EZ, LINE 16: 300,180.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3CHANGES DUE TO FILING AN AMENDED RETURN: UPON COMPLETION OF THE INDEPENDENT FINANCIAL AUDIT, AMOUNTS AND DISCLOSURES ON MOST PARTS OF THE ORIGINALLY FILED 990-EZ RETURN CHANGED. THE FOLLOWING IS A SUMMARY OF ORIGINALLY REPORTED AMOUNTS: 990-EZ, PAGE 1 TOTAL REVENUE (LINE 9) 142,225 TOTAL EXPENSES(LINE 9) 744,548
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4DESCRIPTION: CONTRIBUTIONS RECEIVABLE. BEG. OF YEAR AMOUNT: 675,500. END OF YEAR AMOUNT: 30,000. DESCRIPTION: INVESTMENT IN COVALENT BIOSCIEN. BEG. OF YEAR AMOUNT: 235,824. END OF YEAR AMOUNT: 235,824. DESCRIPTION: PREPAID EXPENSES. BEG. OF YEAR AMOUNT: 3,583. END OF YEAR AMOUNT: 2,953. DESCRIPTION: ACCOUNT RECEIVABLE. BEG. OF YEAR AMOUNT: 1,814. END OF YEAR AMOUNT: 0.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5DESCRIPTION: ACCOUNTS PAYABLE AND ACCRUED EXPENSES. BEG. OF YEAR AMOUNT: 13,890. END OF YEAR AMOUNT: 2,215.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6CHANGES DUE TO FILING AN AMENDED RETURN: UPON COMPLETION OF THE INDEPENDENT FINANCIAL AUDIT, AMOUNTS AND DISCLOSURES ON MOST PARTS OF THE ORIGINALLY FILED 990-EZ RETURN CHANGED. THE FOLLOWING IS A SUMMARY OF ORIGINALLY REPORTED AMOUNTS: 990-EZ, PAGE 2 TOTAL ASSETS (LINE 25) 355,534 TOTAL LIABILITIES(LINE 9) 2,215 NET ASSETS-END OF YEAR (LINE 27) 353,319
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 4 - OTHER INVESTMENT INCOME
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 10 - GRANTS AND SIMILAR AMOUNTS PAID
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PAGES 1-4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990-EZ, PAGES 1-4
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ZACHARY BARNETT
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum03479673734
ReturnHeader/BusinessOfficerGrp/SignatureDt02019-08-19
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ABZYME RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0ABZY
ReturnHeader/Filer/EIN0273438658
ReturnHeader/Filer/PhoneNum03479673734
ReturnHeader/Filer/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FL
ReturnHeader/Filer/USAddress/CityNm0NEW YORK
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010003
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId095362FB61C2BFCAB3B9855A80F88891215CDFAB4
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId095362FB61C2BFCAB3B9855A80F88891215CDFAB4
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt038.122.225.90
ReturnHeader/FilingSecurityInformation/IPDt02019-08-19
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0ED
ReturnHeader/FilingSecurityInformation/IPTm013:51:29
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0133597814
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0SKODY SCOT & CO CPAS PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0520 EIGHTH AVE SUITE 2200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0NEW YORK
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd010018
ReturnHeader/PreparerPersonGrp/PhoneNum02129671100
ReturnHeader/PreparerPersonGrp/PreparationDt02019-08-19
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0LAURENCE SCOT MBA CPA
ReturnHeader/ReturnTs02019-08-19T12:53:18-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02017-01-01
ReturnHeader/TaxPeriodEndDt02017-12-31
ReturnHeader/TaxYr02017

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings